Literature DB >> 32448835

Esophageal Ulcers Associated with Ulcerative Colitis: A Case Series and Literature Review.

Kentaro Tominaga1, Atsunori Tsuchiya1, Hiroki Sato1, Takeshi Mizusawa1, Shinichi Morita2, Yui Ishii1, Nobutaka Takeda1, Kazuki Natsui1, Yuzo Kawata1, Naruhiro Kimura1, Yoshihisa Arao1, Kazuya Takahashi1, Kazunao Hayashi1, Junji Yokoyama1, Shuji Terai1.   

Abstract

Ulcerative colitis, a chronic and recurrent inflammatory disease, is localized to the colonic mucosa but can affect other organs and lead to various complications. Gastroduodenitis associated with ulcerative colitis has been reported. However, little is known about esophageal ulcers. We herein report two rare cases of esophageal ulcers associated with ulcerative colitis. Furthermore, the clinical and histological characteristics of 18 previously reported cases are summarized. This case series and literature review will encourage the accurate diagnosis and treatment of esophageal ulcers associated with ulcerative colitis.

Entities:  

Keywords:  esophageal ulcer; manifestation; ulcerative colitis

Mesh:

Year:  2020        PMID: 32448835      PMCID: PMC7492127          DOI: 10.2169/internalmedicine.4437-20

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Ulcerative colitis (UC) is primarily a disease of the colon; however, extracolonic manifestations have been described. Extracolonic manifestations particularly involve the blood, joints, skin, biliary tracts, liver, kidneys, lungs, and upper digestive tract (1). Gastroduodenitis associated with UC (GDUC) has been noted in 7.6% of severe cases of UC (2, 3), making it a common extracolonic manifestation of UC. In contrast, there have been relatively few reports of esophageal ulcer occurring as an extracolonic manifestation of UC (4). We herein report two cases of UC complicated with esophageal ulcers. Furthermore, we review 18 previously reported cases of esophageal ulcers associated with UC. We summarize these cases to help characterize esophageal ulcer occurring as a complication of UC.

Case Reports

Case 1

A 16-year-old girl presented with chest pain and diarrhea with blood and mucus. No oral, genital ulcers or skin lesions were evident. Esophagogastroduodenoscopy (EGD), showed an ulcer with aphthae in the esophagus (Fig. 1a) and diffuse aphthae in the stomach (Fig. 1b). A histological examination of the esophageal ulcers showed severe inflammatory cell infiltration (Fig. 1d), and the gastric erosions revealed focally enhanced gastritis. Colonoscopy revealed superficial ulcers and mucosal friability (Fig. 1c) from the rectum to the cecum. The terminal ileum was normal. In the histological examination, inflammatory cell infiltration with cryptitis was detected in the sigmoid colon and rectum (Fig. 1e); therefore, pancolitis-type UC was diagnosed comprehensively.
Figure 1.

Esophagogastroduodenoscopy (EGD), colonoscopy, and their pathological findings. (a) EGD showing an ulcer with aphthae (arrows) in the mid intrathoracic esophagus. (b) EGD showing widespread aphthae (arrowheads) at the antrum. (c) Colonoscopy showing erythema and mucosal friability in the sigmoid colon. (d) Biopsy specimen from the esophageal ulcers showing severe inflammatory cell infiltration [Hematoxylin and Eosin (H&E) staining, ×100]. (e) Biopsy specimen from the colon showing inflammatory cell infiltration with cryptitis in the rectum (H&E staining, ×100).

Esophagogastroduodenoscopy (EGD), colonoscopy, and their pathological findings. (a) EGD showing an ulcer with aphthae (arrows) in the mid intrathoracic esophagus. (b) EGD showing widespread aphthae (arrowheads) at the antrum. (c) Colonoscopy showing erythema and mucosal friability in the sigmoid colon. (d) Biopsy specimen from the esophageal ulcers showing severe inflammatory cell infiltration [Hematoxylin and Eosin (H&E) staining, ×100]. (e) Biopsy specimen from the colon showing inflammatory cell infiltration with cryptitis in the rectum (H&E staining, ×100). She was not taking any medicine, including non-steroidal anti-inflammatory drugs, and Helicobacter pylori infection was not confirmed. A serological examination of viral infections (varicella zoster virus, herpes simplex virus, cytomegalovirus, and Epstein-Barr virus-DNA) was also negative. Therefore, esophageal ulcers and gastroduodenitis associated with UC (GDUC) were diagnosed. Treatment with intravenous prednisolone (60 mg/day) was started, and her chest pain and diarrhea were resolved in a few days. EGD on the seventh day showed healing of the esophageal ulcers (Fig. 2a) and gastroduodenal aphthae (Fig. 2b). Colonoscopy showed improvement in the inflammation of the colon (Fig. 2c). She has experienced no relapse for two years.
Figure 2.

Esophagogastroduodenoscopy (EGD) and colonoscopic findings. (a) EGD showing marked healing of the esophageal ulcers (arrows). (b) EGD showing healing of the gastroduodenal aphthae. (c) Colonoscopy showing improvement of mucosal edema and vascular appearance of the sigmoid colon.

Esophagogastroduodenoscopy (EGD) and colonoscopic findings. (a) EGD showing marked healing of the esophageal ulcers (arrows). (b) EGD showing healing of the gastroduodenal aphthae. (c) Colonoscopy showing improvement of mucosal edema and vascular appearance of the sigmoid colon.

Case 2

A 19-year-old woman was admitted to our hospital due to bloody stool and chest pain on swallowing. She was not taking any medication. Laboratory tests showed hypoalbuminemia, mild anemia and inflammatory responses: total protein (6.9 g/dL), albumin (2.8 g/dL), hemoglobin (10.1 g/dL), white blood cell (4,140/mm3), mild neutrophilic leukocytosis (61.6%), thrombocytosis (platelets 28.9×104/μL), and increased C-reactive protein levels (6.88 mg/dL). Stool cultures were normal. Serological assays for viruses, including herpes simplex, cytomegalovirus, varicella, and Epstein-Bar did not demonstrate primary infection. Because of her mouth and chest pain symptoms, EGD was performed, showing a longitudinal ulcer in the lower esophagus (Fig. 3a) and oral ulcers. Histologic findings showed infiltration of inflammatory cells in the epithelia (Fig. 3d). Colonoscopy showed superficial ulcers and mucosal friability (Fig. 3b) in the entire colon, from the rectum to the cecum. We also detected mucosal friability in the terminal ileum (Fig. 3c). The histologic findings here showed inflammatory cell infiltration with basal plasmacytosis in the transverse colon and inflammatory cell infiltration with cryptitis in the rectum (Fig. 3e). She was diagnosed with esophageal ulcer complicated with pancolitis-type UC comprehensively.
Figure 3.

Esophagogastroduodenoscopy (EGD), colonoscopy, and their pathological findings. (a) EGD showing a longitudinal ulcer in the lower esophagus. (b) Colonoscopy showing mucosal friability in the rectum. (c) Colonoscopy showing mucosal friability in the terminal ileum. (d) Biopsy specimen from the esophageal ulcers showing infiltration of inflammatory cells in the epithelia [Hematoxylin and Eosin (H&E) staining, ×100]. (e) Biopsy specimen from the rectum showing inflammatory cell infiltration with basal plasmacytosis and cryptitis (H&E staining, ×100).

Esophagogastroduodenoscopy (EGD), colonoscopy, and their pathological findings. (a) EGD showing a longitudinal ulcer in the lower esophagus. (b) Colonoscopy showing mucosal friability in the rectum. (c) Colonoscopy showing mucosal friability in the terminal ileum. (d) Biopsy specimen from the esophageal ulcers showing infiltration of inflammatory cells in the epithelia [Hematoxylin and Eosin (H&E) staining, ×100]. (e) Biopsy specimen from the rectum showing inflammatory cell infiltration with basal plasmacytosis and cryptitis (H&E staining, ×100). Induction therapy was started with intravenous prednisolone (50 mg/day). Thereafter, her bloody stool and pain on swallowing improved within one week. EGD after four weeks showed healing of the oral and esophageal ulcers (Fig. 4a). Colonoscopy after four weeks also showed complete remission (Fig. 4b). She has shown no relapse of esophageal lesions for one year.
Figure 4.

Esophagogastroduodenoscopy (EGD) and colonoscopic findings. (a) EGD showing healing of the esophageal ulcers. (b) Colonoscopy showing remission of the rectum.

Esophagogastroduodenoscopy (EGD) and colonoscopic findings. (a) EGD showing healing of the esophageal ulcers. (b) Colonoscopy showing remission of the rectum.

Discussion

In 1961, Margoles et al. (5) first reported a case of pancolitis-type UC with esophagitis. There have been 18 reported cases of esophageal ulcers associated with UC, and we encountered 2 new cases ourselves. The previously reported cases of esophageal ulcers associated with UC (case 3 to 20) and our new cases (case 1 and 2) are summarized in Tables 1-3.
Table 1.

Clinical Data of UC Patients with Esophageal Ulcer.

Case (No)Ref No.Age (yrs)SexDuration of UCUC phaseTypeUC treatment
1Ours16F0ActiveTotalPSL
2Ours19F0ActiveTotalPSL
3615M2 yearsRemissionLeft sidePSL, SASP
4723M5 yearsRemissionTotalPSL, SASP
5821F0ActiveN/APLS, SASP
619M0ActiveN/AN/A
71047F0ActiveRight side5ASA
8418F7 yearsRelapse ActiveTotalSASP
91118M1 yearActiveLeft sidePSL, 5ASA
101219M0ActiveTotalnone
111351M0ActiveTotalPSL, 5ASA
121433M0ActiveTotalPSL, LCAP
131552F3 yearsRelapse ActiveLeft sideSASP
14528M17 yearsPost operationTotalTotal colectomy and ileostomy
15826M2 monthsPost operationTotalSbtotal colectomy and ileostomy
1614F5 yearsPost operationTotalSbtotal colectomy and ileostomy
1724M9 yearsPost operationTotalTotal proctocolectomy
18921M3 yearsPost operationTotalTotal colectomy and ileostomy
191647M21 yearsPost operationN/ASbtotal colectomy and ileostomy
2053MN/APost operationTotalSbtotal colectomy

UC: ulcerative colitis, N/A: data not available, PSL: prednisolone, SASP: salazosulfapyridine, 5-ASA: 5-aminosalicylic acid, F: female, M: male

Table 2.

Clinical Data of UC Patients with Esophageal Ulcer.

Case (No)Esophagial ulcer (EU)LocationEU symptoms
1An esophageal ulcer with aphthaeMiddle esophagusChest pain
2Longitudinal oesophageal ulcerLower esophagusChest pain on swallowing
3Severe esophagitisLower esophagusParasternal chest pain and dysphagia
4Shallow ulceration with gross diffuse irregularity and polyp formationMiddle and lower esophagusDysphagia
5Active ulcerative esophagitisN/AN/A
6Marked ulcerative esophagitisN/ASubstenal pain and dysphagia
7Multiple irregular esophageal ulcersWhole esophagusAnterior chest pain and dysphagia
8Longitudinal oesophageal ulcer with haemorrhageMiddle and lower esophagusSore throat and pain on swallowing
9Punched-out esophageal ulcerMiddle esophagusSore throat and anterior chest pain
10Punched-out esophageal ulcerMiddle esophagusGeneral fatigue
11Punched-out esophageal ulcerMiddle and lower esophagusAnterior chest pain on swallowing
12Punched-out esophageal ulcerMiddle and lower esophagusAnterior chest pain and dysphagia
13Punched-out esophageal ulcerMiddle esophagusAnterior chest pain on swallowing
14Web formationMiddle esophagusNo
15Esophagial ulcerations with perforaton into the anterior mediastinumN/ADysphagia, fever, hypotension
16Necrotizing fibrinopurulent ulcerationN/AN/A
17Ulcerative and membranous esophagitisN/ANausea, vomiting and hematemesis
18Multiple friable ulcerationsWhole esophagusSevere odynophagia and dyspahgia
19NecrosisLower esophagusEpigastric pain
20NecrosisMiddle and lower esophagusHematemesis

UC: ulcerative colitis, N/A: data not available

Table 3.

Clinical Data of UC Patients with Esophageal Ulcer.

Case (No)EU biopsyEU treatmentOutcome of EUOther complication
1Severe inflammatory cell infiltrationPSLImprovementNo
2Infiltration of inflammatory cells in the epithelia and no specific informationPSLImprovementOral ulcer
3Superficial inflammationPSLImprovementMaculopapular eruption
4Chronically inflamed and edematous, with a dense infltrate of plasma cells, lymphocytes, and histocytesPSLImprovementBuccal ulceration and arthritis
5N/A--No
6N/A--Necrotic ulceration in the inguinal, genital regions and lower extremities
7Nonspecific findings other than inflammatorycell infiltration5ASA, H2blockerImprovementNo
8Nonspecific findings other than inflammatorycell infiltrationPSLImprovementNo
9Nonspecific findings (Appearance of regenerative epithelium)PSLImprovementOral ulcer and pancreatitis
10Nonspecific findingsPSL, SASPImprovementNo
11Thickening of epithelial stratum spinosum without nuclear inclusion bodyPPIImprovementNo
12Nonspecific findings (Appearance of regenerative epithelium)PPIImprovementNo
13Nonspecific findings other than inflammatorycell infiltrationPSLImprovementNo
14N/APSLN/AMouth and pyoderma gangrenosum
15N/A--Oral ulcerations, pustular dermatitis, arthritis
16N/A--N/A
17N/A--Ulcar of his buttock, paronychia of hands
18Dense infiltrate of polymorphonuclear cells, a few eosinophils and mononuclear cellsPSL, tetracyclineN/AArthritis, episcleritis, oral ulcerations and erythema nodosum
19Inflammatory cell and infiltrationPPIStrictureNo
20Not examinationPPIStrictureNo

UC: ulcerative colitis, EU: esophageal ulcer, N/A: data not available, PSL: prednisolone, SASP: salazosulfapyridine, 5-ASA: 5-aminosalicylic acid, PPI: proton pump inhibitor

Clinical Data of UC Patients with Esophageal Ulcer. UC: ulcerative colitis, N/A: data not available, PSL: prednisolone, SASP: salazosulfapyridine, 5-ASA: 5-aminosalicylic acid, F: female, M: male Clinical Data of UC Patients with Esophageal Ulcer. UC: ulcerative colitis, N/A: data not available Clinical Data of UC Patients with Esophageal Ulcer. UC: ulcerative colitis, EU: esophageal ulcer, N/A: data not available, PSL: prednisolone, SASP: salazosulfapyridine, 5-ASA: 5-aminosalicylic acid, PPI: proton pump inhibitor We reviewed these 20 cases and summarized their findings in Table 1 (4-16). The average age of the patients was 28.2 years (range 14-53), and the ratio of men to women was 14:6. The duration of UC was from 0 to 21 years. There were 13 cases of pancolitis, 3 cases of left-side colitis, 1 case of right-side colitis, and 3 cases with unknown details. Seven of the 18 cases had esophageal ulcers at the onset of UC, and 2 cases had ulcers at the time of UC relapse. Two cases were in UC remission, and 7 cases occurred after total colectomy. According to the review results, esophageal ulcer complications were relatively common in the young compared with the elderly. Furthermore, esophageal ulcer was often complicated in patients at the onset of colitis, or at the time of relapse. It has been reported more aggressive UC entities, such as active pancolitis, may be related to the development of gastroduodenitis associated with UC (GDUC) (2). Furthermore, cases of esophageal ulcers after surgery indicate UC may not be resolved in other organs, even after total colectomy (3). Of the 20 cases, there were 4 cases of multiple esophageal ulcers. There were two cases of entire esophageal ulcer, five of mid-esophageal ulcer, two of lower to middle esophageal ulcer, and five with unknown details. Endoscopic findings of esophageal ulcer complicated with UC were different from GDUC. While GDUC was defined as friable and granular mucosa (2, 3), esophageal ulcer complicated with UC is a punched-out ulcer and mostly occurs in the middle to the lower esophagus. Regarding the pathology, in all cases described, only non-specific inflammatory cell infiltration was observed, with no UC-specific findings reported. Although the relationship between the esophageal ulcers and UC was not confirmed histologically, no other causes of esophageal ulcers were identified, and treatment for UC was also effective for the esophageal lesions. Regarding treatment, 10 cases were treated with prednisolone, and 2 cases received 5-aminosalicylate. GDUC is treated with medications similar to those used for UC (3, 17) and is more responsive to treatment, showing less frequent relapse than colitis. Our two newly reported cases followed a similar course. Of the 18 reported cases, 45% had other complications, namely oral lesions in 7 cases, skin lesions in 6 cases, arthritis in 3 cases, and pancreatitis in 1 case. The case reported by Knudsen and Sparberg (6) had a generalized maculopapular eruption as a complication associated with pancolitis-type UC. The patient reported by Rosendorff (7) had buccal ulceration and arthritis. Most cases of UC with esophageal ulcer have had other extracolonic manifestations. Various extracolonic manifestations of UC, such as ocular lesions, skin disease, and peripheral arthritis, have been reported (1); however, their causes are currently unknown. In conclusion, esophageal ulcer associated with UC is extremely rare. In most cases, it may occur as an extracolonic manifestation. The pathological findings of esophageal lesion are non-specific for UC. Therefore, a comprehensive diagnosis excluding disorders related to infection and medication is required. UC-associated esophageal ulcers are typically associated with the disease onset or relapse of UC. particularly in younger patients, and the treatment response is fortunately considered good. However, the etiology of esophageal ulcer associated with UC remains unknown. Since UC has various pathologies, the accumulation of more cases will be necessary to confirm these findings in the future. The two cases reported in the present study also had atypical aspects and require strict follow-up. We believe that this case series and literature review will facilitate the accurate and prompt diagnosis of esophageal ulcer associated with UC. Informed consent was obtained from the patients for the publication of their information and imaging.

The authors state that they have no Conflict of Interest (COI).

Financial Support

This work was supported by Takeda Japan Medical Office Funded Research Grant 2018.
  11 in total

1.  Stomal ulceration associated with pyoderma gangrenosum and chronic ulcerative colitis. Report of two cases.

Authors:  J S MARGOLES; J WENGER
Journal:  Gastroenterology       Date:  1961-12       Impact factor: 22.682

2.  Diffuse gastroduodenitis associated with ulcerative colitis: treatment by infliximab.

Authors:  Mitsuro Chiba; Iwao Ono; Hideki Wakamatsu; Isao Wada; Katsuhiko Suzuki
Journal:  Dig Endosc       Date:  2012-11-21       Impact factor: 7.559

3.  Relationship of chronic ulcerative esophagitis to ulcerative colitis.

Authors:  N L Christopher; D W Watson; E R Farber
Journal:  Ann Intern Med       Date:  1969-05       Impact factor: 25.391

4.  Apthous ulcers of the esophagus in a patient with ulcerative colitis.

Authors:  H M Zimmerman; G Rosenblum; S Bank
Journal:  Gastrointest Endosc       Date:  1984-10       Impact factor: 9.427

5.  Diagnosis and clinical course of ulcerative gastroduodenal lesion associated with ulcerative colitis: possible relationship with pouchitis.

Authors:  Takashi Hisabe; Toshiyuki Matsui; Masaki Miyaoka; Kazeo Ninomiya; Hiroshi Ishihara; Takashi Nagahama; Yasuhiro Takaki; Fumihito Hirai; Keisuke Ikeda; Akinori Iwashita; Daijiro Higashi; Kitaro Futami
Journal:  Dig Endosc       Date:  2010-10       Impact factor: 7.559

6.  Ulcerative oesophagitis in association with ulcerative colitis.

Authors:  C Rosendorff; N W Grieve
Journal:  Gut       Date:  1967-08       Impact factor: 23.059

7.  Ulcerative esophagitis and ulcerative colitis.

Authors:  K B Knudsen; M Sparberg
Journal:  JAMA       Date:  1967-07-10       Impact factor: 56.272

8.  The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients.

Authors:  A J Greenstein; H D Janowitz; D B Sachar
Journal:  Medicine (Baltimore)       Date:  1976-09       Impact factor: 1.889

9.  Case of ulcerative colitis associated with oesophageal ulcer.

Authors:  A Asakawa; Y Kojima; E Fujii; M Ohtaka; R Shimazaki; T Sato; T Nakamura; A Morozumi; Y Akahane; M A Fujino
Journal:  J Int Med Res       Date:  2000 Jul-Aug       Impact factor: 1.671

10.  Two cases of esophageal ulcer after surgical treatment for ulcerative colitis.

Authors:  Hirosuke Kuroki; Akira Sugita; Kazutaka Koganei; Kenji Tatsumi; Ryo Futatsuki; Katsuhiko Arai
Journal:  Clin J Gastroenterol       Date:  2019-12-20
View more
  1 in total

Review 1.  Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review.

Authors:  Yan Sun; Zhe Zhang; Chang-Qing Zheng; Li-Xuan Sang
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.